These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39490314)

  • 1. Serum peroxiredoxin-4, a biomarker of oxidative stress, associates with new-onset chronic kidney disease: A population-based cohort study.
    Geertsema S; Geertsema P; Kieneker LM; Abdulle AE; la Bastide-van Gemert S; Bakker SJL; Dullaart RPF; Dijkstra G; Gansevoort RT; Faber KN; van Goor H; Bourgonje AR
    Redox Biol; 2024 Nov; 77():103408. PubMed ID: 39490314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.
    Abbasi A; Corpeleijn E; Postmus D; Gansevoort RT; de Jong PE; Gans RO; Struck J; Schulte J; Hillege HL; van der Harst P; Peelen LM; Beulens JW; Stolk RP; Navis G; Bakker SJ
    J Am Heart Assoc; 2012 Oct; 1(5):e002956. PubMed ID: 23316297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
    Bourgonje AR; Abdulle AE; Bourgonje MF; Kieneker LM; la Bastide-van Gemert S; Gordijn SJ; Hidden C; Nilsen T; Gansevoort RT; Mulder DJ; Dullaart RPF; de Borst MH; Bakker SJL; van Goor H
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum free sulfhydryl status associates with new-onset chronic kidney disease in the general population.
    Bourgonje AR; Abdulle AE; Bourgonje MF; Binnenmars SH; Gordijn SJ; Bulthuis MLC; la Bastide-van Gemert S; Kieneker LM; Gansevoort RT; Bakker SJL; Mulder DJ; Pasch A; de Borst MH; van Goor H
    Redox Biol; 2021 Dec; 48():102211. PubMed ID: 34896941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population.
    Piek A; Smit L; Suthahar N; Bakker SJL; de Boer RA; Silljé HHW
    Sci Rep; 2021 Apr; 11(1):8642. PubMed ID: 33883651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General Population.
    Bourgonje AR; Bourgonje MF; la Bastide-van Gemert S; Nilsen T; Hidden C; Gansevoort RT; Mulder DJ; Hillebrands JL; Bakker SJL; Dullaart RPF; van Goor H; Abdulle AE
    Kidney Int Rep; 2024 May; 9(5):1265-1275. PubMed ID: 38707832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    Abbasi A; Corpeleijn E; Gansevoort RT; Gans RO; Struck J; Schulte J; Hillege HL; van der Harst P; Stolk RP; Navis G; Bakker SJ
    Diabetologia; 2014 Sep; 57(9):1842-9. PubMed ID: 24893865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).
    Gerrits EG; Alkhalaf A; Landman GW; van Hateren KJ; Groenier KH; Struck J; Schulte J; Gans RO; Bakker SJ; Kleefstra N; Bilo HJ
    PLoS One; 2014; 9(2):e89719. PubMed ID: 24586984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
    Liu J; Bankir L; Verma A; Waikar SS; Palsson R
    Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
    Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis.
    Schulte J; Struck J; Köhrle J; Müller B
    Shock; 2011 May; 35(5):460-5. PubMed ID: 21283059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
    Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
    Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of serum albumin-to-globulin ratio for incident chronic kidney disease: A 12-year community-based prospective study.
    Park J; Kim HJ; Kim J; Choi YB; Shin YS; Lee MJ
    PLoS One; 2020; 15(9):e0238421. PubMed ID: 32877465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.
    Waikar SS; Srivastava A; Palsson R; Shafi T; Hsu CY; Sharma K; Lash JP; Chen J; He J; Lieske J; Xie D; Zhang X; Feldman HI; Curhan GC;
    JAMA Intern Med; 2019 Apr; 179(4):542-551. PubMed ID: 30830167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.